Pluslife

Pluslife is committed to utilizing next-generation gene technology to develop innovative molecular diagnostic products and gene therapy solutions, exploring the application of gene technology in improving lives. Pluslife was founded by the first group of 'National Distinguished Experts' and has a technical expert team composed of multiple professors and postdoctoral researchers, as well as numerous senior professionals in the fields of in vitro diagnostics and new drug development. Located in Guangzhou, the "City of Rams," Pluslife currently has a 600-square-meter R&D base and a 2,200-square-meter pilot production and manufacturing workshop.In the field of molecular diagnostics, Pluslife's independently developed nucleic acid detection card has achieved true point-of-care testing (POCT) for nucleic acids on a global scale for the first time. This detection card does not rely on laboratory environments or equipment, is easy to operate, and provides results within half an hour after the sample is inserted, with sensitivity and specificity consistent with central laboratories, saving you, your friends, and family significant amounts of valuable time. Pluslife's detection card products cover a wide range of applications, including human influenza and respiratory infections, pediatric infectious disease testing, reproductive-related infectious disease differentiation, personal genotype testing, pet diseases, and animal epidemic detection. Pluslife is collaborating with government departments, healthcare institutions across China, and communities to bring more accurate, convenient, and meaningful testing to everyone. In the future, we will expand our product coverage globally to help more people, which aligns with Pluslife's social responsibility as a biotechnology company.